Researchers
Stanimirov, Bojan
Results 81-100 of 222
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2018 | Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles![]() | Pavlović, Nebojša | Article | 21aM21a |
| 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat![]() | Pavlović, Nebojša | Conference Paper | Mp. category will be shown later |
| 2018 | In Silico Prediction of Bile Acids-drugs Interactions at Transporter Level of Lactobacillus Acidophilus NCFM![]() | Stojančević, Tijana | Conference Paper | Mp. category will be shown later |
| 2018 | Bile acid potentiates apoptosis of human breast adenocarcinoma cells induced by doxorubicin![]() | Stanimirov, Bojan | Conference Paper | Mp. category will be shown later |
| 2018 | Preliminary Study on Probiotic Bacteria Role in Simvastatin Activation![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2018 | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome![]() | Đanić, Maja | Article | 21aM21a |
| 2018 | 12-Monoketocholate: a new perspective in metabolic syndrome treatments | LAZAREVIĆ, SLAVICA | Conference Paper | Mp. category will be shown later |
| 2018 | Ursodeoxycholic acid modulates intracellular redox state and sensitizes colon cancer cells to the cytotoxicity induced by epigenetic agent vorinostat![]() | Pavlović, Nebojša | Conference Paper | Mp. category will be shown later |
| 2018 | Preliminary study on gliclazide–probiotic bacteria interactions in in vitro conditions | ĐANIĆ, MAJA P. | Conference Paper | Mp. category will be shown later |
| 2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics![]() | Mikov, Momir | Article | 23M23 |
| 2018 | Interakcije između gliklazida i probiotskih bakterija u in vitro uslovima![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2017 | Lekovi u prometu 2017 : priručnik o lekovima i njihovoj primeni![]() | Sabo, Ana
Milijašević, Boris
| Other | Mp. category will be shown later |
| 2017 | Nova perspektiva tretmana dijabetes mellitusa: mesto žučnih kiselina, probiotika i gliklazida kao mogući tretman dijabetesa tip 1 | MIKOV, MOMIR M. | Conference Paper | Mp. category will be shown later |
| 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | STANIMIROV, BOJAN G. | Conference Paper | Mp. category will be shown later |
| 2017 | Bile Acid Derivatives as a Promising Metabolic Syndrome Treatment![]() | Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2017 | Preliminary study on probiotic bacteria role in simvastatin activation![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2017 | Dose optimization of antibacterials: plasma vs. tissue concentrations | TOMAS, ANA D. | Conference Paper | Mp. category will be shown later |
| 2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Mikov, Momir | Article | 22M22 |
| 2017 | Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response![]() | Pavlović, Nebojša | Reviews | 21M21 |
| 2017 | Ursodeoxycholic acid sensitizes human breast adenocarcinoma cells to doxorubicin-induced apoptosis | STANIMIROV, BOJAN G. | Conference Paper | Mp. category will be shown later |
